Short-course Radiation (SCRT) Followed by 6 Cycles of Cadonilimab Plus MFOLFOX6 As Neoadjuvant Therapy for Patients with Locally Advanced Rectal Cancer (LARC): a Multicenter, Two-arm Parallel, Open-label, Randomised Phase III Trial (NeoCaCRT-III)
Clinical trial NCT06832917 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06832917
- Sponsor
- Wan He
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-31
- Primary completion
- 2028-12-31
- Enrollment
- 238
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.